Prospective clinical study to evaluate the safety and efficacy of the Versius surgical system in robot-assisted cholecystectomy

CMR Surgical (United Kingdom)0 个研究点目标入组 30 人开始时间: 2022年10月20日最近更新: 2022年10月31日

适应症

试验速览

暂无简介。

•1. Patient deemed suitable for laparoscopic Cholecystectomy procedure using Versius Surgical Robotic System
•2. Patients able to provide written informed consent to participate in the study (with help of appropriate legal representatives if required)
•3. Male and Female, aged 18 years or above
•4. Female of childbearing potential, must not be pregnant and agree to not become pregnant for the duration of the study
•5. Patients with BMI <40 kg/m². Priority BMI 25 to 40 kg/m²

•1. Patient participation in an investigational clinical study within 30 days before screening
•2. Inability or difficulties to provide informed consent
•3. Oncological cases, Patients undergoing surgery or treatment for malignant disease
•4. Patients who fall into American Society of Anaesthesiologists (ASA) ClassIV or above
•5. History of chronic alcohol or drug abuse
•6. Chronic renal failure or on dialysis
•7. Significant medical history or immunocompromised
•8. Subjects with any other clinically significant unstable medical disorder, life-threatening disease, or anything else in the opinion of the Investigator which would contra-indicate a surgical procedure
•9. Patient tested COVID positive within last 30 days of screening
•10. Patient tested COVID positive within 48 hours day the of the procedure
•11. Diabetes mellitus (Glycemia > 11mmol/L ; >200 mg/dL)
•12. Uncontrolled hypertension

发起方

CMR Surgical (United Kingdom)